Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality

被引：39

作者：

Lu, Ding

Vince, Robert

机构：

[1] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Acad Hlth Ctr, Ctr Drug Design, Minneapolis, MN 55455 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 20期

关键词：

HIV-1 protease inhibitor; C-2; symmetry; sulfoximine; transition state mimic;

D O I：

10.1016/j.bmcl.2007.07.095

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Based on the unique property of sulfoximine and the homodimeric Q structural symmetry of HIV-1 protease, a novel class of sulfoximine-based pseudosymmetric HIV-1 protease inhibitors was designed and synthesized. The sulfoximine moiety was demonstrated to be important for HIV-1 protease inhibitor potency. The most active stereoisomer (2S,2 ' S) displays a potency of 2.5 nM (IC50) against HIV-1 protease and an anti-HIV-1 activity of 408 nM (IC50). A possible mode of action is proposed. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：5614 / 5619

页数：6

共 21 条

[1] INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRICAL PHOSPHINATE - SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS
ABDELMEGUID, SS
ZHAO, BG
MURTHY, KHM
WINBORNE, E
CHOI, JK
DESJARLAIS, RL
MINNICH, MD
CULP, JS
DEBOUCK, C
TOMASZEK, TA
MEEK, TD
DREYER, GB
[J]. BIOCHEMISTRY, 1993, 32 (31) : 7972 - 7980
[2] HIGHLY DIASTEREOSELECTIVE ALKYLATIONS OF CHIRAL AMIDE ENOLATES - NEW ROUTES TO HYDROXYETHYLENE DIPEPTIDE ISOSTERE INHIBITORS OF HIV-1 PROTEASE
ASKIN, D
WALLACE, MA
VACCA, JP
REAMER, RA
VOLANTE, RP
SHINKAI, I
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (10) : 2771 - 2773
[3] ACTION OF NITROGEN TRICHLORIDE (AGENE) ON PROTEINS - ISOLATION OF CRYSTALLINE TOXIC FACTOR
BENTLEY, HR
MCDERMOTT, EE
PACE, J
WHITEHEAD, JK
MORAN, T
[J]. NATURE, 1949, 164 (4167) : 438 - 439
[4] Sulfoximines in pseudopeptides
Bolm, C
Kahmann, JD
Moll, G
[J]. TETRAHEDRON LETTERS, 1997, 38 (07) : 1169 - 1172
[5] X-RAY CRYSTAL-STRUCTURE OF THE HIV PROTEASE COMPLEX WITH L-700,417, AN INHIBITOR WITH PSEUDO C2 SYMMETRY
BONE, R
VACCA, JP
ANDERSON, PS
HOLLOWAY, MK
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (24) : 9382 - 9384
[6] Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease
Chen, CA
Sieburth, SM
Glekas, A
Hewitt, GW
Trainor, GL
Erickson-Viitanen, S
Garber, SS
Cordova, B
Jeffry, S
Klabe, RM
[J]. CHEMISTRY & BIOLOGY, 2001, 8 (12): : 1161 - 1166
[7] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS
CONDRA, JH
SCHLEIF, WA
BLAHY, OM
GABRYELSKI, LJ
GRAHAM, DJ
QUINTERO, JC
RHODES, A
ROBBINS, HL
ROTH, E
SHIVAPRAKASH, M
TITUS, D
YANG, T
TEPPLER, H
SQUIRES, KE
DEUTSCH, PJ
EMINI, EA
[J]. NATURE, 1995, 374 (6522) : 569 - 571
[8] EFFECT OF PH ON THE ACTIVITIES OF PENICILLOPEPSIN AND RHIZOPUS PEPSIN AND A PROPOSAL FOR THE PRODUCTIVE SUBSTRATE BINDING MODE IN PENICILLOPEPSIN
HOFMANN, T
HODGES, RS
JAMES, MNG
[J]. BIOCHEMISTRY, 1984, 23 (04) : 635 - 643
[9] SYNTHESIS OF OPTICALLY-ACTIVE SULFOXIMINES FROM OPTICALLY-ACTIVE SULFOXIDES
JOHNSON, CR
KIRCHHOF.RA
CORKINS, HG
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1974, 39 (16) : 2458 - 2459
[10] UTILIZATION OF SULFOXIMINES AND DERIVATIVES AS REAGENTS FOR ORGANIC SYNTHESIS
JOHNSON, CR
[J]. ACCOUNTS OF CHEMICAL RESEARCH, 1973, 6 (10) : 341 - 347

← 1 2 3 →